In this webinar, Dr Yongen Chang discusses the currently known pathophysiology of COVID-19 and important considerations in the care of patients with kidney disease. Read More
Between 2025 and 2060, the number of adult Americans age 18 and older with one or more of the four most common cardiovascular risk factors is projected to rise by… Read More
Compared to other ethnic populations, people of African-Caribbean heritage and living with diabetes have a 57% greater risk of advanced kidney disease. The incidence rate of advanced kidney disease among… Read More
NephU hosts Dr. Debra Hain, a PhD prepared tenured professor and DNP Program Director at Florida Atlantic University’s Christine E Lynn College of Nursing, and Jessica Prohn, RD, a certified… Read More
This article reviews the post-covid landscape and its effects on kidney health. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.